UB Paderborn / Katalog / Suche / in CDI

Impact of vitamin D insufficiency on insulin homeostasis and beta cell function in nondiabetic male HIV‐infected patients

HIV medicine, 2013-10, Vol.14 (9), p.540-548

2013

Volltextzugriff (PDF)

Risk assessment in brain-only oligometastatic non-small cell lung cancer (BOO-NSCLC) patients (pts): Recursive partioning analysis (RPA) model modification

Annals of oncology, 2018-10, Vol.29, p.viii538-viii538

2018

Volltextzugriff (PDF)

137PD Prognostic factors in oligometastatic non-small-cell lung cancer (OM-NSCLC)

Journal of thoracic oncology, 2018-04, Vol.13 (4), p.S80-S80

2018

Volltextzugriff (PDF)

Transarterial chemoembolization with doxorubicin-loaded drug-eluting beads (DEBDOX) in the treatment of breast cancer liver metastases: A pilot study

Annals of oncology, 2015-05, Vol.26, p.iii6-iii6

2015

Volltextzugriff (PDF)

P-281 The GERCOR and Köhne prognostic models in metastatic colorectal cancer (mCRC) patients treated with bevacizumab-based first-line therapy: comparison and validation of both models in a real-life setting

Annals of oncology, 2015-06, Vol.26, p.iv83

2015

Volltextzugriff (PDF)

2326 An internally validated new clinical prognostic score for patients with advanced hepatocellular carcinoma treated with sorafenib

European journal of cancer (1990), 2015-09, Vol.51, p.S441-S441

2015

Volltextzugriff (PDF)

2325 A study of the representativity of the NCIC, PRODIGE and MPACT phase III trials of gemcitabine-erlotinib, FOLFIRINOX and gemcitabine-nab-paclitaxel in patients with advanced pancreatic cancer treated in a real-life setting

European journal of cancer (1990), 2015-09, Vol.51, p.S441-S441

2015

Volltextzugriff (PDF)

1974 Pretreatment neutrophil-to-lymphocyte ratio (NLR) correlates with response to neoadjuvant chemotherapy and survival in breast cancer: A pilot study

European journal of cancer (1990), 2015-09, Vol.51, p.S325-S325

2015

Volltextzugriff (PDF)

2134 Comparative analysis of the Kohne, GERCOR and GEMCAD prognostic models in metastatic colorectal cancer (mCRC) patients treated with first-line bevacizumab-based combination chemotherapy

European journal of cancer (1990), 2015-09, Vol.51, p.S376-S377

2015

Volltextzugriff (PDF)

2288 Validation of the Memorial Sloan Kettering Cancer Center (MSKCC) nomogram after surgery for localized pancreatic adenocarcinoma: Long-term results from a Spanish pancreatic cancer surgery reference centre

European journal of cancer (1990), 2015-09, Vol.51, p.S428-S428

2015

Volltextzugriff (PDF)

145P Perspectives in oligometastatic brain lesions in non-small cell lung cancer (NSCLC)

Journal of thoracic oncology, 2016-04, Vol.11 (4), p.S120-S121

2016

Volltextzugriff (PDF)

159P Early radiological response (ERR) as predictor of overall survival in non small cell lung cancer (NSCLC) patients with EGFR mutations

Journal of thoracic oncology, 2016-04, Vol.11 (4), p.S127-S127

2016

Volltextzugriff (PDF)

144P Oligometastatic non-small-cell lung cancer (NSCLC) and unresectable primary tumor: Updated retrospective analysis of safety and efficacy of the radical treatment for the primary tumor and the metastases

Journal of thoracic oncology, 2016-04, Vol.11 (4), p.S120-S120

2016

Volltextzugriff (PDF)

Patient with chronic osteomyelitis who developed cachexia

Revista clínica espanõla, 2007-11, Vol.207 (10), p.525-526

2007

Volltextzugriff (PDF)

1486PRisk assessment in brain-only oligometastatic non-small cell lung cancer (BOO-NSCLC) patients (pts): Recursive partioning analysis (RPA) model modification

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

P3.08-06 Long-Term Survival for Brain-Only Oligometastatic NSCLC Patients Treated with Ablative Therapy (AT): Prognostic Factors

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S941-S941

2018

Volltextzugriff (PDF)

Risk factors for sexual and erectile dysfunction in HIV-infected men: the role of protease inhibitors

AIDS (London), 2010-01, Vol.24 (2), p.255-264

2010

Volltextzugriff (PDF)

Prognostic factors in oligometastatic non-small-cell lung cancer (OM-NSCLC): 137PD

Journal of thoracic oncology, 2018-04, Vol.13 (4 Suppl), p.S80-S80

2018

Volltextzugriff (PDF)

Impact of second primary tumors of head and neck region after a previous tumor in that area

Annals of oncology, 2016-10, Vol.27, p.vi349-vi349

2016

Volltextzugriff (PDF)

Pancreatitis inducida por capecitabina

Medicina clínica, 2018-06, Vol.150 (11), p.e37-e38

2018

Volltextzugriff (PDF)

Paciente con osteomielitis crónica que desarrolla caquexia

Revista clínica espanõla, 2007-11, Vol.207 (10), p.525-526

2007

Volltextzugriff (PDF)

Application of osmotic dehydration technology on jam processing

Drying technology, 1996, Vol.14 (3/4), p.841-857

1996

Volltextzugriff (PDF)

Perspectives in oligometastatic brain lesions in non-small cell lung cancer (NSCLC): 145P

Journal of thoracic oncology, 2016-04, Vol.11 (4 Suppl), p.S120-S121

2016

Volltextzugriff (PDF)

Oligometastatic non-small-cell lung cancer (NSCLC) and unresectable primary tumor: Updated retrospective analysis of safety and efficacy of the radical treatment for the primary tumor and the metastases: 144P

Journal of thoracic oncology, 2016-04, Vol.11 (4 Suppl), p.S120-S120

2016

Volltextzugriff (PDF)

Early radiological response (ERR) as predictor of overall survival in non small cell lung cancer (NSCLC) patients with EGFR mutations: 159P

Journal of thoracic oncology, 2016-04, Vol.11 (4 Suppl), p.S127-S127

2016

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Impact of vitamin D insufficiency on insulin homeostasis and beta cell function in nondiabetic male HIV‐infected patients

Risk assessment in brain-only oligometastatic non-small cell lung cancer (BOO-NSCLC) patients (pts): Recursive partioning analysis (RPA) model modification

137PD Prognostic factors in oligometastatic non-small-cell lung cancer (OM-NSCLC)

Transarterial chemoembolization with doxorubicin-loaded drug-eluting beads (DEBDOX) in the treatment of breast cancer liver metastases: A pilot study

P-281 The GERCOR and Köhne prognostic models in metastatic colorectal cancer (mCRC) patients treated with bevacizumab-based first-line therapy: comparison and validation of both models in a real-life setting

2326 An internally validated new clinical prognostic score for patients with advanced hepatocellular carcinoma treated with sorafenib

2325 A study of the representativity of the NCIC, PRODIGE and MPACT phase III trials of gemcitabine-erlotinib, FOLFIRINOX and gemcitabine-nab-paclitaxel in patients with advanced pancreatic cancer treated in a real-life setting

1974 Pretreatment neutrophil-to-lymphocyte ratio (NLR) correlates with response to neoadjuvant chemotherapy and survival in breast cancer: A pilot study

2134 Comparative analysis of the Kohne, GERCOR and GEMCAD prognostic models in metastatic colorectal cancer (mCRC) patients treated with first-line bevacizumab-based combination chemotherapy

2288 Validation of the Memorial Sloan Kettering Cancer Center (MSKCC) nomogram after surgery for localized pancreatic adenocarcinoma: Long-term results from a Spanish pancreatic cancer surgery reference centre

145P Perspectives in oligometastatic brain lesions in non-small cell lung cancer (NSCLC)

159P Early radiological response (ERR) as predictor of overall survival in non small cell lung cancer (NSCLC) patients with EGFR mutations

144P Oligometastatic non-small-cell lung cancer (NSCLC) and unresectable primary tumor: Updated retrospective analysis of safety and efficacy of the radical treatment for the primary tumor and the metastases

Patient with chronic osteomyelitis who developed cachexia

1486PRisk assessment in brain-only oligometastatic non-small cell lung cancer (BOO-NSCLC) patients (pts): Recursive partioning analysis (RPA) model modification

P3.08-06 Long-Term Survival for Brain-Only Oligometastatic NSCLC Patients Treated with Ablative Therapy (AT): Prognostic Factors

Risk factors for sexual and erectile dysfunction in HIV-infected men: the role of protease inhibitors

Prognostic factors in oligometastatic non-small-cell lung cancer (OM-NSCLC): 137PD

Impact of second primary tumors of head and neck region after a previous tumor in that area

Pancreatitis inducida por capecitabina

Paciente con osteomielitis crónica que desarrolla caquexia

Application of osmotic dehydration technology on jam processing

Perspectives in oligometastatic brain lesions in non-small cell lung cancer (NSCLC): 145P

Oligometastatic non-small-cell lung cancer (NSCLC) and unresectable primary tumor: Updated retrospective analysis of safety and efficacy of the radical treatment for the primary tumor and the metastases: 144P

Early radiological response (ERR) as predictor of overall survival in non small cell lung cancer (NSCLC) patients with EGFR mutations: 159P

Suchergebnisse filtern